Calithera Biosciences, Inc. (CALA)
OTCMKTS: CALA · Delayed Price · USD
0.0125
-0.0075 (-37.50%)
Jul 25, 2024, 1:33 PM EDT - Market closed
Calithera Biosciences Employees
As of December 31, 2022, Calithera Biosciences had 10 total employees, including 8 full-time and 2 part-time employees. The number of employees decreased by 53 or -84.13% compared to the previous year.
Employees
10
Change (1Y)
-53
Growth (1Y)
-84.13%
Revenue / Employee
n/a
Profits / Employee
$42,200
Market Cap
60.91K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CALA News
- 1 year ago - Calithera Biosciences Announces Update on Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update - GlobeNewsWire
- 1 year ago - Calithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 - GlobeNewsWire
- 1 year ago - Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate - Market Watch
- 1 year ago - Calithera Receives FDA Fast Track Designation for Sapanisertib for the Treatment of NRF2-mutated Squamous Lung Cancer - GlobeNewsWire
- 2 years ago - Calithera to Present at the H.C. Wainwright 24th Annual Global Investment Conference - GlobeNewsWire
- 2 years ago - Calithera Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights - GlobeNewsWire